State Bank of India Rating: ‘Buy’ | Bank managed asset quality well in Q3

Loan growth up to 8% y-y; FY22-24e EPS raised by 4-8% on lower provision estimates; TP revised to Rs 650; ‘Buy’ maintained.

SBI Stock
Fee income grew 7% y-o-y and operating cost growth was low at 1% y-o-y.

For Q3FY22, SBI’s profit of Rs 84 bn, up 62% y-o-y, was below estimate due to higher provisions & lower fees. Key positive was low net-slippages (gross NPLs down 3% q-o-q) & better loan growth (domestic loans up 6% y-o-y). This should be key to lifting its low NII growth of 6% y-o-y. SBI is disclosing NPL flow on a cumulative basis (vs quarterly for peers), which makes comparison difficult. Its high CASA base & corp. book should aid top-line growth. Buy stays.

Well-managed asset quality: During Q3, SBI’s gross NPLs fell by Rs 39 bn q-o-q after adjusting for write-offs of a similar amount (Rs 42 bn). This implies that net slippages (gross slippages less recovery & upgrade) was near-zero. This is low and a tad better than trends for leading banks, but presentation of NPL flows on a cumulative basis vs. quarterly for peers makes it less comparable – we hope mgmt. will change this. Provisions at 1.1% of average loans included provisions on NPLs, stressed loans (possibly Future group) and securitised receipts. Gross NPL fell to 4.5% of loans and total stressed loans are manageable (including restructured loans of 1.5% and ECLG of 1.2%). Coverage on NPLs is adequate at 71% and the bank carries buffer provisions at 0.4%. We see credit costs staying low at ~1% over FY23-24 and downside to that could lift earnings estimates.

Loan growth improves; SME is key: Overall loan growth improved from 6% in Q2 to 8% y-o-y in Q3. While the low-margin international loans grew faster at 21% y-o-y, even domestic loan growth improved from 5% in Q2 to 6%. There was some improvement in SME loans (partly led by disbursals of ECLG lines) and momentum on retail credit is strong; corporate lending remains soft. This is positive as it would lift NII growth that has moderated to 6% y-o-y, among the weakest across leading banks. We expect slight pick-up in loan growth from current levels and see 10% CAGR over FY21-24e, lower than key private bank peers.

Other operating details & subs’ performance: Fee income grew 7% y-o-y and operating cost growth was low at 1% y-o-y. Core PPOP was up 10% y-o-y. MTM treasury losses on G-Secs were low. Subsidiaries are growing well with SBI Life’s VNB up 66% y-o-y, SBI Cards’ profit up 28% & SBI Funds’ profit up 29% y-o-y.

BUY stays: We tweak our FY22-24 EPS by 4-8% as we incorporate lower provision estimates. ROA is low at ~0.8%, but leverage lifts ROE to ~14%. We continue with our Buy rating and roll forward our PT to Rs 650 (from Rs 600) based on 1.5x Dec-23E adj. PB for the bank.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express Telegram Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.